Abstract
Distamycin nitrogen mustard derivatives with different substituents at the amidino moiety located at the C-terminal of the peptide were synthesized. The in vitro antitumor activity was determined against human chronic leukemia K562 cells. Compound 3, bearing a terminal ethylamido group, had the best antitumor activity with an IC50 value of 0.72 μM. Compound 5, bearing a terminal dimethylamino group, had an IC50 value of 2.0 μM. This result suggests that a terminal positive charge is not essential for optimal antitumor activity.
Keywords: Distamycin, Nitrogen mustard, DNA alkylation
Letters in Drug Design & Discovery
Title: Synthesis and Preliminary Antitumor Activity of Distamycin Nitrogen Mustards
Volume: 4 Issue: 1
Author(s): Yuqiang Wang, Zhaoqi Yang, Susan C. Wright and James W. Larrick
Affiliation:
Keywords: Distamycin, Nitrogen mustard, DNA alkylation
Abstract: Distamycin nitrogen mustard derivatives with different substituents at the amidino moiety located at the C-terminal of the peptide were synthesized. The in vitro antitumor activity was determined against human chronic leukemia K562 cells. Compound 3, bearing a terminal ethylamido group, had the best antitumor activity with an IC50 value of 0.72 μM. Compound 5, bearing a terminal dimethylamino group, had an IC50 value of 2.0 μM. This result suggests that a terminal positive charge is not essential for optimal antitumor activity.
Export Options
About this article
Cite this article as:
Wang Yuqiang, Yang Zhaoqi, Wright C. Susan and Larrick W. James, Synthesis and Preliminary Antitumor Activity of Distamycin Nitrogen Mustards, Letters in Drug Design & Discovery 2007; 4 (1) . https://dx.doi.org/10.2174/157018007778992955
DOI https://dx.doi.org/10.2174/157018007778992955 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers